Navigation Links
More evidence that allergies may help in fighting brain tumors
Date:10/18/2011

PROVIDENCE, R.I. [Brown University] A study published online Oct. 18 in the Journal of the National Cancer Institute provides some new but qualified support for the idea that the immune system's response to allergies may reduce the risk of developing deadly brain tumors.

People with somewhat elevated blood levels of immunoglobulin E (IgE), antibodies that carry out the body's immune response to allergens, were significantly less likely to develop gliomas, and those who did survived somewhat longer, than those with clinically normal IgE levels, according to the study by a team of researchers at Brown University and several other institutions in the United States and Europe.

"These results suggest that there is something different about the immune response to tumor cells in people with allergies," said corresponding author Dominique Michaud, associate professor of epidemiology in the Public Health Program at Brown University. "In terms of fighting the cancer or preventing it from growing, people who have allergies might be protected. They might be able to better to fight the cancer."

Questions answered, questions raised

The new study employed a methodology that addresses questions raised by previous studies that have also reported similar associations between IgE, or allergy symptoms, and brain tumors. Instead of asking people who have or have not been diagnosed with brain tumors to describe their allergy history or to take IgE tests, the study delved into the detailed records of tens of thousands of people who participated in four broad-based health studies: the Physicians' Health Study, the Nurses' Health Study, the Women's Health Study, and the Health Professionals Follow-up Study.

Such "prospective" analysis of samples collected from patients before they were diagnosed or treated for brain tumors, allowed the researchers to measure the association between IgE and brain cancer risk without worry that the IgE levels were affected by the course of the disease and treatments for it.

"This is really the first study to look at total IgE levels collected prior to disease," Michaud said. "This is important in being able to determine whether this is a causal effect."

Although the pool of patients in the four studies was large, the actual number of relevant cases was small. Only 169 people with stored plasma subsequently developed brain tumors. They were matched with 520 control subjects (otherwise similar people who did not develop tumors). The small numbers blunted some of the study's results.

For example, the researchers found a statistically significant reduction in glioma risk among people with borderline elevated IgE levels (in a range of 25,000 to 100,000 units per liter), but not for people with even higher levels of IgE. Michaud acknowledged that further research would be needed to explain why the protective effect couldn't be measured in people with the highest IgE levels.

Ultimately, Michaud said, by strengthening the evidence that allergic immune response may affect brain tumors, the study may encourage cancer researchers to focus on the biological mechanisms underlying this association and provide insight into the disease and its treatment.


'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Related medicine news :

1. Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC)
2. Evidence-based care and outcomes improve at Get With The Guidelines-Stroke hospitals
3. Researchers find further evidence linking Epstein-Barr virus and risk of multiple sclerosis
4. More Evidence That Swings in Blood Pressure Raise Stroke Risk
5. Cellular pathway could provide evidence of how cancer and obesity are linked
6. Palladians Distinguished Clinicians Present at APTAs National CSM Convention in San Diego on Evidenced Informed Management of Chronic Low Back Pain Without Surgery
7. Pew Applauds Federal Grant Program Supporting State Expansion of Evidence-Based Home Visitation
8. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
9. Evidence-based medicine theory can be applied to frequent flying says US professor
10. No Evidence That Lithium Helps in ALS
11. UNC study offers first clinical evidence of anti-cancer drug triggering viral infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
Breaking Medicine Technology: